Since losing the weight and reducing inflammation, I dont need it anymore
Ask a clinician first if you have heart, kidney, thyroid, seizure, pregnancy, breastfeeding, or medication concerns
In contrast, GLP-1sincluding semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)represent a significant departure from previous treatment paradigms.[127] By mimicking natural satiety signals and regulating appetite through the gut-brain axis, these medications offer a new kind of intervention that can address core drivers of obesity.[128] Clinical trials have demonstrated average weight loss of 15 percent, comparable to outcomes previously only achievable through bariatric surgery.[129] This level of efficacy, combined with growing demand, marks a potential inflection point in how obesity is treated
Your prior authorization has not been completed
Some issues improve within weeks, while others require several months of structured rehabilitation